TY - JOUR
T1 - Angiography derived assessment of the coronary microcirculation
T2 - is it ready for prime time?
AU - Zhou, Jinying
AU - Onuma, Yoshinobu
AU - Garg, Scot
AU - Kotoku, Nozomi
AU - Kageyama, Shigetaka
AU - Masuda, Shinichiro
AU - Ninomiya, Kai
AU - Huo, Yunlong
AU - Reiber, Johan H.C.
AU - Tu, Shengxian
AU - Piek, Jan J.
AU - Escaned, Javier
AU - Perera, Divaka
AU - Bourantas, Christos
AU - Yan, Hongbing
AU - W. Serruys, Patrick
N1 - Funding Information:
J Zhou declares scholarship from Chinese Scholarship Council (202106210330). PW Serruys declares consulting fees from Philips/Volcano, SMT, Xeltis, Novartis, and Merillife. N Kotoku declares a research grant from Fukuda Foundation for Medical Technology. S Tu declares consultancy and grants from Pulse Medical.
Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Introduction: Non-obstructive coronary arteries (NOCA) are present in 39.7% to 62.4% of patients who undergo elective angiography. Coronary microcirculation (<400 µm) is not visible on angiography therefore functional assessment, invasive or noninvasive plays a prior role to help provide a more personalized diagnosis of angina. Area covered: In this review, we revisit the pathophysiology, clinical importance, and invasive assessment of the coronary microcirculation, and discuss angiography-derived indices of microvascular resistance. A comprehensive literature review over four decades is also undertaken. Expert opinion: The coronary microvasculature plays an important role in flow autoregulation and metabolic regulation. Invasive assessment of microvascular resistance is a validated modality with independent prognostic value, nevertheless, its routine application is hampered by the requirement of intravascular instrumentation and hyperemic agents. The angiography-derived index of microvascular resistance has emerged as a promising surrogate in pilot studies, however, more data are needed to validate and compare the diagnostic and prognostic accuracy of different equations as well as to illustrate the relationship between angiography-derived parameters for epicardial coronary arteries and those for the microvasculature.
AB - Introduction: Non-obstructive coronary arteries (NOCA) are present in 39.7% to 62.4% of patients who undergo elective angiography. Coronary microcirculation (<400 µm) is not visible on angiography therefore functional assessment, invasive or noninvasive plays a prior role to help provide a more personalized diagnosis of angina. Area covered: In this review, we revisit the pathophysiology, clinical importance, and invasive assessment of the coronary microcirculation, and discuss angiography-derived indices of microvascular resistance. A comprehensive literature review over four decades is also undertaken. Expert opinion: The coronary microvasculature plays an important role in flow autoregulation and metabolic regulation. Invasive assessment of microvascular resistance is a validated modality with independent prognostic value, nevertheless, its routine application is hampered by the requirement of intravascular instrumentation and hyperemic agents. The angiography-derived index of microvascular resistance has emerged as a promising surrogate in pilot studies, however, more data are needed to validate and compare the diagnostic and prognostic accuracy of different equations as well as to illustrate the relationship between angiography-derived parameters for epicardial coronary arteries and those for the microvasculature.
KW - angina with non-obstructive coronary artery
KW - angiography
KW - Coronary microvascular
KW - index of microvascular resistance
KW - ischemia with non-obstructive coronary artery
UR - http://www.scopus.com/inward/record.url?scp=85135695853&partnerID=8YFLogxK
U2 - 10.1080/14779072.2022.2098117
DO - 10.1080/14779072.2022.2098117
M3 - Review article
AN - SCOPUS:85135695853
SN - 1477-9072
VL - 20
SP - 549
EP - 566
JO - Expert review of cardiovascular therapy
JF - Expert review of cardiovascular therapy
IS - 7
ER -